MiR-107 was introduced by Hong and colleagues indicating that circHIPK3 downregulated miR-107, reversing its inhibitive effect on brain-derived neurotrophic factor (BDNF), which facilitated NSCLC progression [27]. This evidence concerns the gene BDNF and non-small cell lung carcinoma.